Cagrilintide 10MG

Cagrilintide 10MG | Long-Acting Amylin Analogue

A non-selective amylin receptor agonist designed for advanced research into weight homeostasis and satiety signaling.

Cagrilintide is a long-acting analogue of the pancreatic hormone amylin. In modern obesity research, it is studied for its ability to induce weight loss by promoting satiety and reducing energy intake. It is frequently researched in conjunction with GLP-1 analogues to investigate potential additive effects on metabolic regulation.

Research Benchmarks: Satiety & Metabolic Control

• Caloric Intake Reduction: Studying the peptide’s impact on central nervous system satiety signals.
• Gastric Emptying: Investigating the modulation of digestive transit times.
• Synergy Studies: Researching the combined impact of Cagrilintide and Semaglutide on body weight reduction.

Scientific Reference Library

• 🧪 Research: Efficacy and safety of Cagrilintide in weight management studies
• 🧪 Research: Dual agonism of amylin and GLP-1 receptors
• 🧪 Research: Mechanisms of amylin-mediated appetite suppression